Yanina Jansen

1.5k total citations
48 papers, 887 citations indexed

About

Yanina Jansen is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Yanina Jansen has authored 48 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 18 papers in Molecular Biology and 13 papers in Surgery. Recurrent topics in Yanina Jansen's work include Cancer Immunotherapy and Biomarkers (19 papers), Melanoma and MAPK Pathways (15 papers) and CAR-T cell therapy research (11 papers). Yanina Jansen is often cited by papers focused on Cancer Immunotherapy and Biomarkers (19 papers), Melanoma and MAPK Pathways (15 papers) and CAR-T cell therapy research (11 papers). Yanina Jansen collaborates with scholars based in Belgium, Netherlands and United States. Yanina Jansen's co-authors include Bart Neyns, Max Schreuer, Teofila Seremet, Hendrik Everaert, Inès Chevolet, Brigitte Velkeniers, Bert Bravenboer, Jeroen de Filette, Vibeke Krüse and Sofie Wilgenhof and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Yanina Jansen

44 papers receiving 869 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanina Jansen Belgium 15 595 345 221 192 156 48 887
Sangeetha M. Reddy United States 15 499 0.8× 256 0.7× 169 0.8× 248 1.3× 139 0.9× 29 830
Suthee Rapisuwon United States 11 683 1.1× 329 1.0× 104 0.5× 246 1.3× 158 1.0× 30 997
Marta Santisteban Spain 16 582 1.0× 308 0.9× 264 1.2× 161 0.8× 134 0.9× 55 957
Yien Ning Sophia Wong United Kingdom 8 687 1.2× 387 1.1× 284 1.3× 325 1.7× 350 2.2× 17 1.1k
Giuseppina Della Vittoria Scarpati Italy 15 407 0.7× 438 1.3× 313 1.4× 116 0.6× 172 1.1× 44 973
Sanjeeve Balasubramaniam United States 17 454 0.8× 280 0.8× 204 0.9× 177 0.9× 149 1.0× 33 920
Prakash Kharel United States 6 739 1.2× 249 0.7× 93 0.4× 342 1.8× 205 1.3× 13 1.0k
Erwan Pencreach France 17 350 0.6× 323 0.9× 248 1.1× 82 0.4× 200 1.3× 35 797
Alejandro Avilés‐Salas Mexico 14 369 0.6× 295 0.9× 186 0.8× 81 0.4× 249 1.6× 62 768

Countries citing papers authored by Yanina Jansen

Since Specialization
Citations

This map shows the geographic impact of Yanina Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanina Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanina Jansen more than expected).

Fields of papers citing papers by Yanina Jansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanina Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanina Jansen. The network helps show where Yanina Jansen may publish in the future.

Co-authorship network of co-authors of Yanina Jansen

This figure shows the co-authorship network connecting the top 25 collaborators of Yanina Jansen. A scholar is included among the top collaborators of Yanina Jansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanina Jansen. Yanina Jansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Slambrouck, Jan Van, Xin Jin, Elena Prisciandaro, et al.. (2025). Temperature dynamics of donor lungs from procurement to reperfusion: Static ice versus controlled hypothermic storage. The Journal of Heart and Lung Transplantation. 44(11). 1737–1746. 1 indexed citations
2.
Raemdonck, Dirk Van, et al.. (2024). Pulmonary Inflammatory Myofibroblastic Tumor: A Case Report. SHILAP Revista de lepidopterología. 12(1). e73–e76. 1 indexed citations
3.
Ridder, Kirsten De, Yanina Jansen, Ann De Becker, et al.. (2024). The crosstalk between lung cancer and the bone marrow niche fuels emergency myelopoiesis. Frontiers in Immunology. 15. 1397469–1397469. 1 indexed citations
4.
Brussaard, Carola, Lorenzo Faggioni, Yanina Jansen, et al.. (2024). Differentiation between normal and metastatic lymph nodes in patients with skin melanoma: Preliminary findings using a DIXON-based whole-body MRI approach. European Journal of Radiology Open. 12. 100560–100560. 1 indexed citations
5.
Peeters, Maxim, Yanina Jansen, Jean H. T. Daemen, et al.. (2024). The use of intravenous indocyanine green in minimally invasive segmental lung resections: a systematic review. Translational Lung Cancer Research. 13(3). 612–622. 3 indexed citations
7.
Daemen, Jean H. T., Aimée J P M Franssen, Yanina Jansen, et al.. (2023). Modification of the Abramson procedure for minimally invasive repair of pectus carinatum: introduction of a pectus carinatum compression system. Journal of Thoracic Disease. 15(7). 4120–4129. 3 indexed citations
8.
Daemen, Jean H. T., et al.. (2022). Translation, cultural adaptation and linguistic validation of the pectus excavatum evaluation questionnaire. Journal of Thoracic Disease. 14(7). 2556–2564. 2 indexed citations
9.
Jansen, Yanina, Astrid A.M. van der Veldt, Gil Awada, & Bart Neyns. (2022). Anti-PD-1: When to Stop Treatment. Current Oncology Reports. 24(7). 905–915. 11 indexed citations
10.
Versluis, Judith M., Alison M. Weppler, Lauren Brown, et al.. (2020). 1080MO The value of local therapy in treatment of solitary melanoma progression upon immune checkpoint inhibition. Annals of Oncology. 31. S733–S734. 1 indexed citations
12.
13.
Seremet, Teofila, Alexander Koch, Yanina Jansen, et al.. (2016). Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients. Journal of Translational Medicine. 14(1). 232–232. 24 indexed citations
14.
Jansen, Yanina, Elisa A. Rozeman, Marnix Geukes Foppen, et al.. (2016). Correlation between baseline characteristics and clinical outcome of patients with advanced melanoma treated with pembrolizumab (PEMBRO). Annals of Oncology. 27. vi386–vi386. 4 indexed citations
15.
Schreuer, Max, Geert Meersseman, Yanina Jansen, et al.. (2016). Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors. Journal of Translational Medicine. 14(1). 95–95. 116 indexed citations
16.
Schreuer, Max, Vibeke Krüse, Yanina Jansen, & Bart Neyns. (2016). COMBI-rechallenge: a phase II clinical trial on dabrafenib plus trametinib in BRAFV600-mutant melanoma patients who previously experienced progression on BRAF(+MEK)-inhibition. Annals of Oncology. 27. vi389–vi389. 1 indexed citations
17.
Seremet, Teofila, Danielle Líénard, Mariano Suppa, et al.. (2015). Successful (neo)adjuvant BRAF-targeted therapy in a patient with locally advanced BRAF V600E mutant melanoma. Melanoma Research. 25(2). 180–183. 10 indexed citations
18.
Jansen, Yanina, Peter Janssens, Anne Hoorens, et al.. (2015). Granulomatous nephritis and dermatitis in a patient with BRAF V600E mutant metastatic melanoma treated with dabrafenib and trametinib. Melanoma Research. 25(6). 550–554. 33 indexed citations
19.
Bel, Annelies De, et al.. (2014). Yersinia ruckeri, an unusual microorganism isolated from a human wound infection. New Microbes and New Infections. 2(4). 134–135. 18 indexed citations
20.
Schreuer, Max, Inès Chevolet, Yanina Jansen, et al.. (2014). Objective responses can be obtained by CTLA-4 inhibition in metastatic melanoma after BRAF inhibitor failure. Melanoma Research. 25(1). 68–74. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026